Portal de Periódicos da CAPES

Syntheses, biochemical and biological evaluation of staurosporine analogues from the microbial metabolite rebeccamycin

1998; Elsevier BV; Volume: 6; Issue: 9 Linguagem: Inglês

10.1016/s0968-0896(98)00096-0

1464-3391

Fabrice Anizon, Pascale Moreau, Martine Sancelme, Aline Voldoire, Michelle Prudhomme, Monique Ollier, Danièle Sevère, Jean‐François Riou, Christian Bailly, Doriano Fabbro, Thomas Meyer, A.‐M. Aubertin,

Bioactive Compounds and Antitumor Agents

The indolocarbazole antibiotics staurosporine and rebeccamycin (1) are potent antitumor drugs targeting protein kinase C and topoisomerase I, respectively. To obtain staurosporine analogues from rebeccamycin, different structural modifications were performed: coupling of the sugar moiety to the second indole nitrogen, dechlorination and then reduction of the imide function to amide. The newly synthesized compounds (3-6) were tested for their abilities to bind to DNA and to inhibit topoisomerase I and protein kinase C. Their antiproliferative effects in vitro against B16 melanoma and P388 leukemia (including the related P388CPT cell line resistant to camptothecin) as well as their anti-HIV-1 and antimicrobial activities against various strains of microorganisms were determined. The cytotoxicity of the dechlorinated imide analogue 5 correlates well with its DNA binding and anti-topoisomerase I activities. These findings provide guidance for the development of new topoisomerase I-targeted antitumor indolocarbazoles equipped with a carbohydrate attached to the two indole nitrogens.